Seeking Alpha

Seeking Alpha Portfolio App for iPad

401 people get RBGPF.PK articles and Market Currents by email alert.

Get email alerts on RBGPF.PK »

RBGPF.PK

Reckitt Benckiser

5/19/2013, 5:29 PM ET

Quote & Headlines Market Currents StockTalk

All
| Earnings
| Dividends
| M&A
| On the move

Tuesday, February 12, 8:15 AM Bristol-Myers Squibb (BMY) licenses the rights to sell several of its top-selling medicines in Latin America to Reckitt Benckiser (RBGPY.PK) for $482M. Under the deal, the British company will be able to sell the medicines in countries such as Brazil and Mexico, and it has an option to acquire the brands outright after three years. (PR) Comment! [Consumer, Healthcare, M&A]
Wednesday, November 21, 2012, 4:54 PM A day after Bayer ruled out raising its offer for Schiff Nutrition (SHF), Reckitt Benckiser (RBGPF.PK) announces a definitive merger agreement at $42/share, valuing SHF at $1.4B. Reckitt says it will finance the deal with cash and existing credit facilities. Comment! [Healthcare, Consumer, M&A]
Tuesday, November 20, 2012, 9:10 AM Premarket gainers: GMCR +12%. KKD +11%. GRPN +10%. CHS +5%. QIHU +5%.
Losers: HPQ -10%. CLF -6%. BBY -6%. SHF -5%. Comment! [On the Move]
Tuesday, November 20, 2012, 8:02 AM Bayer (BAYZF.PK) decides to avoid getting enmeshed in a bidding war for Schiff Nutrition (SHF -5.3%), saying it won't increase its $1.2B proposal for the U.S. company after Reckitt Benckiser (RBGPF.PK) offered $1.4B. "Entering a competitive bidding process in response to the November 18 Proposal (Reckitt's bid) would result in a price outside Bayer's set financial criteria," the German drug maker says. Comment! [Healthcare, On the Move, M&A]
Friday, November 16, 2012, 12:45 PM Midday top 10 gainers: SWSH +30%. PENN +30%. SHF +30%. OMX +20%. PRAN +17%. CCBG +20%. ASCA +15%. SUMR +14%. KWK +14%. OSIS +12%. Midday top 10 Losers: DIAL -76%. SAB -51%. DVAX -47%. SCMR -24%. BORN -20%. VIAS -18%. GAIA -18%. SHLD -17%. SINA -15%. EDS -15%. 2 Comments
Friday, November 16, 2012, 9:10 AM Premarket gainers: PENN +33%. SHF +29%. SWSH +22%. OMX +17%. ASCA +17%. CLNT +15%. BYD +12%. STSI +11%. MGM +7%. OSIS +6%. LVS +6%. VRNG +6%. GMCR +5%. CALI +5%. FRO +5%.
Losers: DVAX -48%. SINA -7%. Comment! [On the Move]
Friday, November 16, 2012, 5:14 AM Schiff Nutrition (SHF) shares surged 30% to $44.10 in post-market trading after it became the subject of a bidding war. Reckitt Benckiser (RBGPF.PK) has offered $1.4B, or $42/share, to acquire Schiff, topping a $1.2B proposal from Bayer (BAYZF.PK). Buying Schiff would enable Reckitt to enter the $30B market for vitamins and supplements, a temptation that analysts think could prompt J&J (JNJ) into making a bid as well. Comment! [Financials, Consumer]
Tuesday, November 6, 2012, 9:36 AM Taking multivitamins every day didn't reduce the risk of a heart attack or stroke in an 11-year study of over 14,500 men over the age of 50, although there did seem to be a reduced risk of cancer. Companies that operate in the sector include Pfizer (PFE), which supplied the vitamins for the study, NBTY (NTY) and Schiff (SHF). 2 Comments [Healthcare]
Thursday, November 1, 2012, 1:24 PM A number of firms weigh in on Schiff Nutrition (SHF +0.4%) following yesterdays news of a takeover by Bayer (BAYRY.PK). Imperial Capital cuts it to In-Line, saying that although it doesn't expect any competing offers, SHF still has the opportunity to review unsolicited bids up until November 28th. Gabelli also reduced its rating to Hold, while DA Davidson lowers it to Neutral, noting that further upside is limited. Comment! [Healthcare, M&A]
Wednesday, October 31, 2012, 12:45 PM Midday top 10 gainers: SHF +46%. WRC +37%. OPNT +29%. RRGB +25%. MPAC +23%. RCON +23%. HNSN +20%. CVLT +20%. ARWR +20%. GPRE +19%. Midday top 10 Losers: IQNT -35%. OXF -31%. BCRX -29%. WU -28%. PBIB -25%. CRNT -24%. CHRM -20%. CBAK -18%. RVBD -19%. NBG -18%. 2 Comments [On the Move]
Tuesday, October 30, 2012, 4:44 AM Bayer (BAYZF.PK) agrees to acquire Schiff Nutrition (SHF) for $1.2B in cash, with the $34-a-share offer representing a 47% premium to the latter's close on Friday. The deal strengthens Bayer's presence in the U.S., the biggest market in the world for over-the-counter and nutritional products. Separately, Bayer's Q3 EBITDA edges up to €1.85B as sales rise 12% to €9.67B. (PR: merger, earnings) Comment! [Healthcare, M&A]
Tuesday, September 18, 2012, 12:05 AM Notable earnings before Tuesday’s open: FDX, SHF Comment! [Dividends]
Monday, September 17, 2012, 5:30 PM Notable earnings before Tuesday’s open: FDX, SHF Comment! [Dividends]
Tuesday, July 31, 2012, 9:13 AM Schiff Nutrition (SHF): FQ4 EPS of $0 misses by $0.11. Revenue of $67.4M (0% Y/Y) beats by $7.2M. (PR) Comment! [Earnings, Healthcare]
Monday, April 2, 2012, 3:16 PM Schiff Nutrition (WNI +4%) acquires Airborne from GF Capital Management for $150M in cash, giving it control of the well-known maker of cold-fighting tablets and allowing it to expand its position in the immune-support market. Comment! [U.S. Economy]
Thursday, March 22, 2012, 7:08 AM Schiff Nutrition International (WNI): FQ3 EPS of $0.16 beats by $0.04. Revenue of $72.2M (+25% Y/Y) beats by $6.6M. (PR) Comment! [Earnings, Healthcare]